ST. PAUL, MN--(Marketwire - May 27, 2008) - GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, today releases an update to its shareholders and the investment community.
